Lung MetastasesSymptoms, Doctors, Treatments, Advances & More
Learn About Lung Metastases
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Warren Clinic Pulmonology
Walter Boomer is a Pulmonary Medicine provider practicing medicine in Tulsa, Oklahoma. He has been practicing medicine for over 41 years. Dr. Boomer is rated as a Distinguished provider by MediFind in the treatment of Lung Metastases. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), Lung Nodules, Pneumonia, and Gastrostomy.
OSF Medical Group - Lung & Pulmonology
Jon Michel is an Intensive Care Medicine specialist and a Sleep Medicine provider practicing medicine in Peoria, Illinois. Dr. Michel is rated as a Distinguished provider by MediFind in the treatment of Lung Metastases. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Lung Metastases, Emphysema, Bullae, Gastrostomy, and Endoscopy. Dr. Michel is board certified in American Board Of Internal Medicine and United Council For Neurologic Subspecialties.
Aurora Pulmonology
Raul Ayala is a Pulmonary Medicine provider practicing medicine in Green Bay, Wisconsin. Dr. Ayala is rated as a Distinguished provider by MediFind in the treatment of Lung Metastases. He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), Emphysema, Lung Nodules, and Advanced Bronchoscopy. Dr. Ayala is board certified in American Board Of Internal Medicine, Pulmonary Disease.
Summary: Papillary thyroid cancer (PTC) is the most common form of differentiated thyroid cancer (DTC). The traditional first line treatment for patients with advanced DTC after surgical resection is radioactive iodine (RAI) therapy. However, less than a quarter of patients with lung metastases will achieve a complete response to RAI therapy, and this therapy carries the risk of pulmonary fibrosis and an i...
Summary: This is a Phase 3, multi-center, randomized and intrasubject controlled study to evaluate the safety and efficacy of abenacianine for injection, a tumor-targeted, activatable fluorescent imaging agent, to identify cancer using NIR imaging in participants undergoing surgery for cancer in the lung. Approximately 132 partiipants will be enrolled to ensure a minimum of 115 evaluable participants recei...